Calmiren en es it fr

Calmiren Brand names, Calmiren Analogs

Calmiren Brand Names Mixture

  • No information avaliable

Calmiren Chemical_Formula


Calmiren RX_link

No information avaliable

Calmiren fda sheet

Calmiren msds (material safety sheet)

Calmiren Synthesis Reference

No information avaliable

Calmiren Molecular Weight

309.469 g/mol

Calmiren Melting Point

< 25 oC

Calmiren H2O Solubility

Soluble as HCl salt

Calmiren State


Calmiren LogP


Calmiren Dosage Forms

Tablets (oral, 1 mg)

Calmiren Indication

Used for the symptomatic treatment of parkinsonism.

Calmiren Pharmacology

Metixene is a tertiary antimuscarinic with actions similar to those of atropine; it also has antihistaminic and direct antispasmodic properties. It is used for the symptomatic treatment of parkinsonism, including the alleviation of the extrapyramidal syndrome induced by other drugs such as phenothiazines, but, like other antimuscarinics, it is of no value against tardive dyskinesias. Metixene has been discontinued.

Calmiren Absorption

Absorbed in the gastrointestinal tract following oral administration, however the extent of absorption is not known.

Calmiren side effects and Toxicity

Signs of overdose include dilated and sluggish pupils, warm, dry skin, facial flushing, decreased secretions of the mouth, pharynx, nose, and bronchi, foul-smelling breath, elevated temperature, tachycardia, cardiac arrhythmias, decreased bowel sounds, urinary retention, delirium, disorientation, anxiety, hallucinations, illusions, confusion, incoherence, agitation, hyperactivity, ataxia, loss of memory, paranoia, combativeness, and seizures.

Calmiren Patient Information

Calmiren Organisms Affected

Humans and other mammals